Letter to the editor: Treating portal vein thrombosis in cirrhosis: is anticoagulation therapy overestimated?

Ng CH, Tan DJH, Nistala KRY, Syn N, Xiao J, Tan EXX, et al. A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis. Hepatol Int. 2021;15(5):1196–1206

Article  Google Scholar 

Driever EG, von Meijenfeldt FA, Adelmeijer J, de Haas RJ, van den Heuvel MC, Nagasami C, et al. Non-malignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus. Hepatology. 2022;75(4):898–911

CAS  Article  Google Scholar 

Chun HS, Choe AR, Lee M, Cho Y, Kim HY, Yoo K, et al. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis. Clin Mol Hepatol. 2021;27(4):535–552

Article  Google Scholar 

Ai MH, Dong WG, Tan XP, Xu L, Xu C, Zhang Q, et al. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2020;32:1395–1400

CAS  Article  Google Scholar 

Lv Y, Bai W, Li K, Wang Z, Guo W, Luo B, et al. Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study. Am J Gastroenterol. 2021;116(7):1447–1464

Article  Google Scholar 

留言 (0)

沒有登入
gif